TranS1 TSON Fraud Lawsuit: Losses?



Our law firm wants to speak to investors who lost money in Trans1 TSON stock.

TranS1 Inc. Defrauded Investors?

Securities fraud claims may be brought against TranS1, Inc. (TSON).  TranS1 based in Wilmington, North Carolina makes medical devices that treat degenerative conditions of the spine.

On October 17, 2011, TranS1 announced in its SEC filing that they were being investigated for medicare fraud and had received a subpoena for documents from the U.S. Department of Health and Human Services (HHS).

TranS1's SEC filing stated that HHS’s Office of the Inspector General issued the subpoena “under the authority of the federal healthcare fraud and false claims statutes.”  The subpoena seeks documents from January 1, 2008, through October 6, 2011. 

TranS1’s shares fell more than 40% to close at $1.85.

If you invested in TranS1 between March 25, 2008 through October 17, 2011 please call Attorney Bill Kyros at 1-800-934-2921 to discuss your rights.

Kyros Law is a Boston-based law firm with significant experience representing investors in shareholder lawsuits, class actions, shareholder derivative actions, and securities fraud class actions. For info about our law firm please our Kyros Law web site.